Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Boston Scientific Corporation (BSX) vs Cintas Corporation (CTAS) Price & Performance

Boston Scientific CorporationTrade
Cintas CorporationTrade

Price performance (Past 24H)

Key statistics

Boston Scientific Corporation vs Cintas Corporation — how do they compare? Boston Scientific Corporation trades at $51 (market cap $71.46B), while Cintas Corporation trades at $205.28 (market cap $81.25B). The key difference: Boston Scientific Corporation and Cintas Corporation are close in size by market cap, and Cintas Corporation pays a 1.02% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.

BSXCTAS
Market Cap
$71.46B$81.25B
Sector
HealthIndustrials
52-Week High
$108.14$225.10
52-Week Low
$42.63$163.55
Enterprise Value
$83.55B$83.67B
Dividend Yield
1.02%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Boston Scientific Corporation

No Aura AI signal available yet.

Cintas Corporation

Cintas (CTAS) trades at $203.05, up 0.45% on the day, with a bullish technical signal and strong fundamental performance. The company reported Q2 2026 EPS of $1.29, beating estimates, and revenue growth continues with a 17.75% net income margin. Recent news highlights Bank of America's upgrade to 'Buy' and a quarterly dividend announcement, reflecting confidence in its outlook.

The outlook for CTAS is positive, supported by consistent earnings beats and robust profitability, though high valuation multiples like a P/E of 41.35 pose a risk. Upside exists toward the consensus price target of $225.83, but investors should monitor competitive pressures and economic sensitivity.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Read more on BSX

About Cintas Corporation

In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).

Read more on CTAS